Polycystic ovary syndrome (PCOS) is a common endocrine disorder affecting women of reproductive age. It is characterized by a variety of symptoms, including irregular menstrual cycles, infertility, obesity, hirsutism, acne, and insulin resistance. PCOS is a complex disorder, and its pathogenesis remains largely unknown. Despite its prevalence, PCOS is often underdiagnosed or misdiagnosed due to the lack of a clear diagnostic criteria. This article aims to provide an overview of PCOS and its management, in order to help physicians better recognize and treat the disorder.
PCOS is a heterogeneous disorder with variable presentations. It is characterized by anovulation, hyperandrogenism, and polycystic ovarian morphology. Anovulation is defined as the absence of ovulation, and is the most common symptom of PCOS. Hyperandrogenism is the presence of elevated androgens, such as testosterone, in the blood. Polycystic ovarian morphology is the presence of multiple small cysts in the ovaries, which can be seen on ultrasound.
The diagnosis of PCOS is based on the presence of two of the three criteria: anovulation, hyperandrogenism, and polycystic ovarian morphology. Anovulation can be diagnosed by a history of irregular menstrual cycles, or by monitoring for ovulation with basal body temperature or urinary luteinizing hormone (LH) tests. Hyperandrogenism can be diagnosed by measuring serum testosterone and other androgens. Polycystic ovarian morphology can be diagnosed by transvaginal ultrasound.
PCOS is associated with a number of complications, including infertility, obesity, hirsutism, acne, and insulin resistance. Infertility is the most common complication of PCOS, and is caused by the lack of ovulation. Obesity is also common in PCOS, and is thought to be due to insulin resistance. Hirsutism, acne, and insulin resistance can also be caused by the elevated androgens associated with PCOS.
The management of PCOS depends on the patient's individual presentation and goals. For those with fertility issues, ovulation induction with drugs such as clomiphene citrate or gonadotropins may be recommended. For those with hirsutism, acne, or obesity, lifestyle modifications such as diet and exercise as well as medications such as metformin or spironolactone may be recommended.
PCOS is a complex disorder that affects many women of reproductive age. It is characterized by anovulation, hyperandrogenism, and polycystic ovarian morphology, and is associated with a number of complications, including infertility, obesity, hirsutism, acne, and insulin resistance. The diagnosis of PCOS is based on the presence of two of the three criteria, and the management of PCOS depends on the patient's individual presentation and goals. With a better understanding of PCOS and its management, physicians can help women better recognize and treat the disorder.
1.
Potential targets for treating the most common type of liver cancer in children have been identified by a collaborative study.
2.
Study identifies new approach to protect the brain during radiation therapy
3.
While most cancer screenings won't prolong lives, there are still good reasons to continue screening.
4.
Chemo-Free Quadruplet Shows Promise as DLBCL's First Therapy.
5.
Radiation therapy for patients with breast cancer
1.
Radiation in Oncology: Advances, Applications, and Accessibility
2.
The Next Generation of Precision: How Multi-Specific Antibodies are Redefining Oncology's Future - A 2025 Review
3.
Cracking Oncology Drug Resistance: New Strategies to Overcome Challenges in Modern Cancer Therapy
4.
Unlocking the Secrets of Neutrophils: Exploring Their Role in Immune Defense
5.
Precision Oncology: Personalized Medicine Shaping the Future of Cancer Care
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
3.
Navigating the Complexities of Ph Negative ALL - Part XIII
4.
Navigating the Complexities of Ph Negative ALL - Part IV
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation